Entering text into the input field will update the search result below

Thermo Fisher among bidders to acquire Baxter's biopharma unit – Reuters

Mar. 21, 2023 1:38 PM ETThermo Fisher Scientific Inc. (TMO), BAXKKR, CGBy: Dulan Lokuwithana, SA News Editor6 Comments

Thermo Fisher Scientific office in Whitby, On, Canada.

JHVEPhoto/iStock Editorial via Getty Images

  • Thermo Fisher Scientific (NYSE:TMO) and South Korea-based Celltrion Inc. are among those vying to acquire the biopharma solutions business of Baxter International (NYSE:BAX), Reuters reported Tuesday, citing people familiar with the matter.
  • In January, Baxter (

Recommended For You

Comments (6)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Another Mountain's Rock Investing profile picture
TMO is a buyer, while Baxter, Danaher, and many more firms sell off their assets. In other words, TMO remains top of the class.
@another Mountain's Rock Investing Right. And it's priced that way. BAX may be more promising as an investment.
Another Mountain's Rock Investing profile picture
@jemicarus sometimes it is better to invest in good companies rather than expect things to change. multiple ways to go about it though.
@another Mountain's Rock Investing But is Baxter's Biopharma a good investment? TMO already has good representation in CRO and manufacturing.

I don't follow Baxter, but their chart and a long string of missed earnings looks pretty bad.

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.